Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 May 15;340(Pt 1):17–24.

Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.

C Warnecke 1, T Willich 1, J Holzmeister 1, S P Bottari 1, E Fleck 1, V Regitz-Zagrosek 1
PMCID: PMC1220217  PMID: 10229654

Abstract

To investigate mechanisms of human angiotensin II type 2 receptor (hAT2) gene regulation we functionally characterized the promoter and downstream regions of the gene. 5'-Terminal deletion mutants from -1417/+100 to -46/+100 elicited significant but low functional activity in luciferase reporter gene assays with PC12W cells. Inclusion into the promoter constructs of intron 1 and the transcribed region of the hAT2 gene up to the translation start enhanced luciferase activity 6.7+/-1.6-fold and 11.6+/-1.7-fold (means+/-S.E.M.) respectively, whereas fusion of the promoter to the spliced 5' untranslated region of hAT2 cDNA did not, which indicated an enhancement caused by intronic sequence elements. Reverse transcriptase-mediated PCR confirmed that the chimaeric hAT2-luciferase mRNA was regularly spliced in PC12W cells. A Northern blot analysis of transfected cells showed levels of luciferase mRNA expression consistent with the respective enzyme activities. Mapping of intron 1 revealed that a 12 bp sequence in the centre of the intron was required for the increase in promoter activity, whereas the 5' adjacent intronic region mediated a decrease in luciferase activity. Mutation of the 12 bp region led to altered protein binding and markedly decreased luciferase activity. Cloned into a promoterless luciferase vector, a 123 bp intron 1 fragment was able to direct reporter gene expression to the same activity as occurred in conjunction with the 5' flanking region. These results indicate that sequence elements in intron 1 are necessary for efficient transcription of hAT2. In reporter gene assays, intron 1 might by itself function as a promoter and initiate transcription from an alternative start point.

Full Text

The Full Text of this article is available as a PDF (227.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albanesi C., Geremia R., Giorgio M., Dolci S., Sette C., Rossi P. A cell- and developmental stage-specific promoter drives the expression of a truncated c-kit protein during mouse spermatid elongation. Development. 1996 Apr;122(4):1291–1302. doi: 10.1242/dev.122.4.1291. [DOI] [PubMed] [Google Scholar]
  2. Bedecs K., Elbaz N., Sutren M., Masson M., Susini C., Strosberg A. D., Nahmias C. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J. 1997 Jul 15;325(Pt 2):449–454. doi: 10.1042/bj3250449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bottari S. P., King I. N., Reichlin S., Dahlstroem I., Lydon N., de Gasparo M. The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem Biophys Res Commun. 1992 Feb 28;183(1):206–211. doi: 10.1016/0006-291x(92)91629-5. [DOI] [PubMed] [Google Scholar]
  4. Bucher P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol. 1990 Apr 20;212(4):563–578. doi: 10.1016/0022-2836(90)90223-9. [DOI] [PubMed] [Google Scholar]
  5. Camp H. S., Dudley D. T. Modulation of angiotensin II receptor (AT2) mRNA levels in R3T3 cells. Receptor. 1995 Summer;5(2):123–132. [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Curnow K. M., Pascoe L., Davies E., White P. C., Corvol P., Clauser E. Alternatively spliced human type 1 angiotensin II receptor mRNAs are translated at different efficiencies and encode two receptor isoforms. Mol Endocrinol. 1995 Sep;9(9):1250–1262. doi: 10.1210/mend.9.9.7491117. [DOI] [PubMed] [Google Scholar]
  8. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Grady E. F., Sechi L. A., Griffin C. A., Schambelan M., Kalinyak J. E. Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991 Sep;88(3):921–933. doi: 10.1172/JCI115395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hein L., Barsh G. S., Pratt R. E., Dzau V. J., Kobilka B. K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature. 1995 Oct 26;377(6551):744–747. doi: 10.1038/377744a0. [DOI] [PubMed] [Google Scholar]
  11. Holzmeister J., Graf K., Warnecke C., Fleck E., Regitz-Zagrosek V. Protein kinase C-dependent regulation of the human AT1 promoter in vascular smooth muscle cells. Am J Physiol. 1997 Aug;273(2 Pt 2):H655–H664. doi: 10.1152/ajpheart.1997.273.2.H655. [DOI] [PubMed] [Google Scholar]
  12. Horiuchi M., Hayashida W., Kambe T., Yamada T., Dzau V. J. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem. 1997 Jul 25;272(30):19022–19026. doi: 10.1074/jbc.272.30.19022. [DOI] [PubMed] [Google Scholar]
  13. Horiuchi M., Koike G., Yamada T., Mukoyama M., Nakajima M., Dzau V. J. The growth-dependent expression of angiotensin II type 2 receptor is regulated by transcription factors interferon regulatory factor-1 and -2. J Biol Chem. 1995 Aug 25;270(34):20225–20230. doi: 10.1074/jbc.270.34.20225. [DOI] [PubMed] [Google Scholar]
  14. Horiuchi M., Yamada T., Hayashida W., Dzau V. J. Interferon regulatory factor-1 up-regulates angiotensin II type 2 receptor and induces apoptosis. J Biol Chem. 1997 May 2;272(18):11952–11958. doi: 10.1074/jbc.272.18.11952. [DOI] [PubMed] [Google Scholar]
  15. Ichiki T., Inagami T. Transcriptional regulation of the mouse angiotensin II type 2 receptor gene. Hypertension. 1995 Apr;25(4 Pt 2):720–725. doi: 10.1161/01.hyp.25.4.720. [DOI] [PubMed] [Google Scholar]
  16. Ichiki T., Kambayashi Y., Inagami T. Multiple growth factors modulate mRNA expression of angiotensin II type-2 receptor in R3T3 cells. Circ Res. 1995 Dec;77(6):1070–1076. doi: 10.1161/01.res.77.6.1070. [DOI] [PubMed] [Google Scholar]
  17. Ichiki T., Labosky P. A., Shiota C., Okuyama S., Imagawa Y., Fogo A., Niimura F., Ichikawa I., Hogan B. L., Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995 Oct 26;377(6551):748–750. doi: 10.1038/377748a0. [DOI] [PubMed] [Google Scholar]
  18. Janiak P., Pillon A., Prost J. F., Vilaine J. P. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension. 1992 Dec;20(6):737–745. doi: 10.1161/01.hyp.20.6.737. [DOI] [PubMed] [Google Scholar]
  19. Kambayashi Y., Bardhan S., Inagami T. Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1993 Jul 15;194(1):478–482. doi: 10.1006/bbrc.1993.1844. [DOI] [PubMed] [Google Scholar]
  20. Kambayashi Y., Nagata K., Ichiki T., Inagami T. Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular-smooth-muscle cells. Eur J Biochem. 1996 Aug 1;239(3):558–565. doi: 10.1111/j.1432-1033.1996.0558u.x. [DOI] [PubMed] [Google Scholar]
  21. Kijima K., Matsubara H., Murasawa S., Maruyama K., Mori Y., Inada M. Gene transcription of angiotensin II type 2 receptor is repressed by growth factors and glucocorticoids in PC12 cells. Biochem Biophys Res Commun. 1995 Nov 2;216(1):359–366. doi: 10.1006/bbrc.1995.2632. [DOI] [PubMed] [Google Scholar]
  22. Kijima K., Matsubara H., Murasawa S., Maruyama K., Ohkubo N., Mori Y., Inada M. Regulation of angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway. Hypertension. 1996 Mar;27(3 Pt 2):529–534. doi: 10.1161/01.hyp.27.3.529. [DOI] [PubMed] [Google Scholar]
  23. Kobayashi S., Ohnishi J., Nibu Y., Nishimatsu S., Umemura S., Ishii M., Murakami K., Miyazaki H. Cloning of the rat angiotensin II type 2 receptor gene and identification of its functional promoter region. Biochim Biophys Acta. 1995 Jun 9;1262(2-3):155–158. doi: 10.1016/0167-4781(95)00076-s. [DOI] [PubMed] [Google Scholar]
  24. Lazard D., Briend-Sutren M. M., Villageois P., Mattei M. G., Strosberg A. D., Nahmias C. Molecular characterization and chromosome localization of a human angiotensin II AT2 receptor gene highly expressed in fetal tissues. Receptors Channels. 1994;2(4):271–280. [PubMed] [Google Scholar]
  25. Lopez J. J., Lorell B. H., Ingelfinger J. R., Weinberg E. O., Schunkert H., Diamant D., Tang S. S. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol. 1994 Aug;267(2 Pt 2):H844–H852. doi: 10.1152/ajpheart.1994.267.2.H844. [DOI] [PubMed] [Google Scholar]
  26. Madsen C. S., Regan C. P., Hungerford J. E., White S. L., Manabe I., Owens G. K. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence. Circ Res. 1998 May 4;82(8):908–917. doi: 10.1161/01.res.82.8.908. [DOI] [PubMed] [Google Scholar]
  27. Martin M. M., Elton T. S. The sequence and genomic organization of the human type 2 angiotensin II receptor. Biochem Biophys Res Commun. 1995 Apr 17;209(2):554–562. doi: 10.1006/bbrc.1995.1537. [DOI] [PubMed] [Google Scholar]
  28. Nakajima M., Hutchinson H. G., Fujinaga M., Hayashida W., Morishita R., Zhang L., Horiuchi M., Pratt R. E., Dzau V. J. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10663–10667. doi: 10.1073/pnas.92.23.10663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nio Y., Matsubara H., Murasawa S., Kanasaki M., Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest. 1995 Jan;95(1):46–54. doi: 10.1172/JCI117675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Orzechowski H. D., Richter C. M., Funke-Kaiser H., Kröger B., Schmidt M., Menzel S., Bohnemeier H., Paul M. Evidence of alternative promoters directing isoform-specific expression of human endothelin-converting enzyme-1 mRNA in cultured endothelial cells. J Mol Med (Berl) 1997 Jul;75(7):512–521. doi: 10.1007/s001090050136. [DOI] [PubMed] [Google Scholar]
  31. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995 Dec 11;23(23):4878–4884. doi: 10.1093/nar/23.23.4878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Regitz-Zagrosek V., Friedel N., Heymann A., Bauer P., Neuss M., Rolfs A., Steffen C., Hildebrandt A., Hetzer R., Fleck E. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation. 1995 Mar 1;91(5):1461–1471. doi: 10.1161/01.cir.91.5.1461. [DOI] [PubMed] [Google Scholar]
  33. Regitz-Zagrosek V., Neuss M., Warnecke C., Holzmeister J., Hildebrandt A. G., Fleck E. Subtype 2 and atypical angiotensin receptors in the human heart. Basic Res Cardiol. 1996;91 (Suppl 2):73–77. doi: 10.1007/BF00795366. [DOI] [PubMed] [Google Scholar]
  34. Reil H., Hauser H. Test system for determination of HIV-1 frameshifting efficiency in animal cells. Biochim Biophys Acta. 1990 Aug 27;1050(1-3):288–292. doi: 10.1016/0167-4781(90)90183-3. [DOI] [PubMed] [Google Scholar]
  35. Schlaeger T. M., Bartunkova S., Lawitts J. A., Teichmann G., Risau W., Deutsch U., Sato T. N. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3058–3063. doi: 10.1073/pnas.94.7.3058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Showe M. K., Williams D. L., Showe L. C. Quantitation of transient gene expression after electroporation. Nucleic Acids Res. 1992 Jun 25;20(12):3153–3157. doi: 10.1093/nar/20.12.3153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Voigtländer T., Ganten D., Bader M. Transcriptional regulation of the rat renin gene by regulatory elements in intron I. Hypertension. 1999 Jan;33(1 Pt 2):303–311. doi: 10.1161/01.hyp.33.1.303. [DOI] [PubMed] [Google Scholar]
  38. Wharton J., Morgan K., Rutherford R. A., Catravas J. D., Chester A., Whitehead B. F., De Leval M. R., Yacoub M. H., Polak J. M. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J Pharmacol Exp Ther. 1998 Jan;284(1):323–336. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES